Corrigendum to “Anti- E. coli immunoglobulin yolk (IgY): Reduction of pathogen receptors and inflammation factors could be caused by decrease in E. coli load” [Heliyon 9(3) (February 21, 2023) e13876]>

“Researchers would like to thank the Deanship of Scientific Research, Qassim University for funding publication this project”.“This work was supported by a grant from University” Anti-E. coli Immunoglobulin Yolk (IgY): Reduction pathogen receptors and inflammation factors could be caused decrease in E. loadBouazzaoui et al.HeliyonFebruary 21, 2023In BriefGraft versus host disease (GVHD) remains major cause morbidity mortality after allogeneic stem cell transplantation, especially intestinal GVHD, as steroid resistant GVHD results high mortality. For reason, new treatments are needed. One approach is reduction pathogenic bacteria using anti-E. (IgY). In haploidentical murine model, B6D2F1 mice conditioned with total body irradiation (TBI), received bone marrow cells (BM) splenocytes (SC) either syngeneic (Syn = B6D2F1) or (Allo C57BL/6) donors. Full-Text PDF Open Access